Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 285

1.

The Role of Complement in Liver Injury, Regeneration, and Transplantation.

Thorgersen EB, Barratt-Due A, Haugaa H, Harboe M, Pischke SE, Nilsson PH, Mollnes TE.

Hepatology. 2019 Aug;70(2):725-736. doi: 10.1002/hep.30508. Epub 2019 Jul 15. Review.

PMID:
30653682
2.

Ephrin-A1-EphA4 signaling negatively regulates myelination in the central nervous system.

Harboe M, Torvund-Jensen J, Kjaer-Sorensen K, Laursen LS.

Glia. 2018 May;66(5):934-950. doi: 10.1002/glia.23293. Epub 2018 Jan 19.

PMID:
29350423
3.

Properdin binding to complement activating surfaces depends on initial C3b deposition.

Harboe M, Johnson C, Nymo S, Ekholt K, Schjalm C, Lindstad JK, Pharo A, Hellerud BC, Nilsson Ekdahl K, Mollnes TE, Nilsson PH.

Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E534-E539. doi: 10.1073/pnas.1612385114. Epub 2017 Jan 9.

4.

Axo-Glia Interaction Preceding CNS Myelination Is Regulated by Bidirectional Eph-Ephrin Signaling.

Linneberg C, Harboe M, Laursen LS.

ASN Neuro. 2015 Sep 8;7(5). pii: 1759091415602859. doi: 10.1177/1759091415602859. Print 2015 Sep-Oct.

5.

Association between leukocyte telomere length and bone mineral density in women 25-93 years of age.

Nielsen BR, Linneberg A, Bendix L, Harboe M, Christensen K, Schwarz P.

Exp Gerontol. 2015 Jun;66:25-31. doi: 10.1016/j.exger.2015.04.004. Epub 2015 Apr 11.

PMID:
25868397
6.

Camel and bovine chymosin: the relationship between their structures and cheese-making properties.

Langholm Jensen J, Mølgaard A, Navarro Poulsen JC, Harboe MK, Simonsen JB, Lorentzen AM, Hjernø K, van den Brink JM, Qvist KB, Larsen S.

Acta Crystallogr D Biol Crystallogr. 2013 May;69(Pt 5):901-13. doi: 10.1107/S0907444913003260. Epub 2013 Apr 19.

7.

The role of properdin in zymosan- and Escherichia coli-induced complement activation.

Harboe M, Garred P, Lindstad JK, Pharo A, Müller F, Stahl GL, Lambris JD, Mollnes TE.

J Immunol. 2012 Sep 1;189(5):2606-13. doi: 10.4049/jimmunol.1200269. Epub 2012 Jul 30.

8.

Advances in assay of complement function and activation.

Harboe M, Thorgersen EB, Mollnes TE.

Adv Drug Deliv Rev. 2011 Sep 16;63(12):976-87. doi: 10.1016/j.addr.2011.05.010. Epub 2011 Jun 2. Review.

PMID:
21664392
9.

Monitoring the aggregation of single casein micelles using fluorescence microscopy.

Bomholt J, Moth-Poulsen K, Harboe M, Karlson AO, Qvist KB, Bjørnholm T, Stamou DG.

Langmuir. 2011 Feb 1;27(3):866-9. doi: 10.1021/la1035163. Epub 2011 Jan 4.

PMID:
21204574
10.

Evidence for waning of latency in a cohort study of tuberculosis.

Wiker HG, Mustafa T, Bjune GA, Harboe M.

BMC Infect Dis. 2010 Feb 23;10:37. doi: 10.1186/1471-2334-10-37.

11.

Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies.

Hellerud BC, Aase A, Herstad TK, Naess LM, Kristiansen LH, Trøseid AM, Harboe M, Lappegård KT, Brandtzaeg P, Høiby EA, Mollnes TE.

Infect Immun. 2010 Feb;78(2):802-9. doi: 10.1128/IAI.01044-09. Epub 2009 Nov 23.

12.

Professor emeritus Jacob B. Natvig, one of the founders of Scandinavian journal of immunology, turns 75.

Capra JD, Frøland SS, Harboe M, Jonsson R, Ljunggren HG, Wigzell H.

Scand J Immunol. 2009 Dec;70(6):503-4. doi: 10.1111/j.1365-3083.2009.02343.x. No abstract available.

13.

The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification.

Harboe M, Garred P, Karlstrøm E, Lindstad JK, Stahl GL, Mollnes TE.

Mol Immunol. 2009 Dec;47(2-3):373-80. doi: 10.1016/j.molimm.2009.09.005. Epub 2009 Oct 1.

PMID:
19800125
14.

Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature.

Lappegård KT, Christiansen D, Pharo A, Thorgersen EB, Hellerud BC, Lindstad J, Nielsen EW, Bergseth G, Fadnes D, Abrahamsen TG, Høiby EA, Schejbel L, Garred P, Lambris JD, Harboe M, Mollnes TE.

Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15861-6. doi: 10.1073/pnas.0903613106. Epub 2009 Aug 26.

15.

Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis.

Castellheim A, Brekke OL, Espevik T, Harboe M, Mollnes TE.

Scand J Immunol. 2009 Jun;69(6):479-91. doi: 10.1111/j.1365-3083.2009.02255.x. Review.

16.

Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood.

Salvesen B, Nielsen EW, Harboe M, Saugstad OD, Mollnes TE.

Mol Immunol. 2009 Feb;46(4):688-94. doi: 10.1016/j.molimm.2008.09.001. Epub 2008 Oct 31.

PMID:
18950866
17.

The alternative complement pathway revisited.

Harboe M, Mollnes TE.

J Cell Mol Med. 2008 Aug;12(4):1074-84. doi: 10.1111/j.1582-4934.2008.00350.x. Epub 2008 Apr 15. Review.

18.

Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci.

Norheim G, Aseffa A, Yassin MA, Mengistu G, Kassu A, Fikremariam D, Tamire W, Merid Y, Høiby EA, Caugant DA, Fritzsønn E, Tangen T, Melak B, Berhanu D, Harboe M, Kolberg J, Rosenqvist E.

Clin Vaccine Immunol. 2008 May;15(5):863-71. doi: 10.1128/CVI.00252-07. Epub 2008 Mar 12.

19.

Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7.

Norheim G, Aseffa A, Yassin MA, Mengistu G, Kassu A, Fikremariam D, Tamire W, Merid Y, Høiby EA, Caugant DA, Fritzsønn E, Tangen T, Alebel T, Berhanu D, Harboe M, Rosenqvist E.

Clin Vaccine Immunol. 2007 Apr;14(4):451-63. Epub 2007 Feb 14.

20.

[The new face of tuberculosis in Norway].

Harboe M.

Tidsskr Nor Laegeforen. 2006 Oct 19;126(20):2682-3. Norwegian. No abstract available.

21.

[This is not our medical ethic].

Harboe M.

Tidsskr Nor Laegeforen. 2006 Sep 7;126(17):2283. Norwegian. No abstract available.

22.

Female genital tuberculosis in Ethiopia.

Abebe M, Lakew M, Kidane D, Lakew Z, Kiros K, Harboe M.

Ethiop Med J. 2004 Apr;42 Suppl 1:37-41.

PMID:
16895018
23.

T cell mediated immune responses in patients with tuberculous lymphadenitis from Butajira, southern Ethiopia.

Habte A, Geletu M, Olobo JO, Kidane D, Negesse Y, Yassin MA, Kifle B, Abate G, Harboe M, Aseff A.

Ethiop Med J. 2004 Apr;42 Suppl 1:29-35.

PMID:
16895017
24.

Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions.

Harboe M, Garred P, Borgen MS, Stahl GL, Roos A, Mollnes TE.

Clin Exp Immunol. 2006 Jun;144(3):512-20.

25.

Increased production of chymosin by glycosylation.

van den Brink HJ, Petersen SG, Rahbek-Nielsen H, Hellmuth K, Harboe M.

J Biotechnol. 2006 Sep 1;125(2):304-10. Epub 2006 Apr 18.

PMID:
16621086
26.

Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989.

Norheim G, Rosenqvist E, Aseffa A, Yassin MA, Mengistu G, Kassu A, Fikremariam D, Tamire W, Høiby EA, Alebel T, Berhanu D, Merid Y, Harboe M, Caugant DA.

J Clin Microbiol. 2006 Mar;44(3):861-71.

27.

Challenges presented by nerve damage in leprosy.

Harboe M, Aseffa A, Leekassa R.

Lepr Rev. 2005 Mar;76(1):5-13. Review.

PMID:
15881032
28.

The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation.

Harboe M, Ulvund G, Vien L, Fung M, Mollnes TE.

Clin Exp Immunol. 2004 Dec;138(3):439-46.

29.

Female genital tuberculosis in Ethiopia.

Abebe M, Lakew M, Kidane D, Lakew Z, Kiros K, Harboe M.

Int J Gynaecol Obstet. 2004 Mar;84(3):241-6.

PMID:
15001372
30.

Immunodominant B-cell epitope in the Mce1A mammalian cell entry protein of Mycobacterium tuberculosis cross-reacting with glutathione S-transferase.

Harboe M, Das AK, Mitra D, Ulvund G, Ahmad S, Harkness RE, Das D, Mustafa AS, Wiker HG.

Scand J Immunol. 2004 Feb;59(2):190-7.

31.

Nasal carriage of Mycobacterium leprae DNA in healthy individuals in Lega Robi village, Ethiopia.

Beyene D, Aseffa A, Harboe M, Kidane D, Macdonald M, Klatser PR, Bjune GA, Smith WC.

Epidemiol Infect. 2003 Oct;131(2):841-8.

32.

Diagnosis of tuberculous lymphadenitis in Butajira, rural Ethiopia.

Yassin MA, Olobo JO, Kidane D, Negesse Y, Shimeles E, Tadesse A, Demissie A, Britton S, Harboe M, Aseffa A, Abate G.

Scand J Infect Dis. 2003;35(4):240-3.

PMID:
12839151
33.

Predicted molecular structure of the mammalian cell entry protein Mce1A of Mycobacterium tuberculosis.

Das AK, Mitra D, Harboe M, Nandi B, Harkness RE, Das D, Wiker HG.

Biochem Biophys Res Commun. 2003 Mar 14;302(3):442-7.

PMID:
12615052
34.

T- and B-cell epitopes in the secreted Mycobacterium bovis antigen MPB70 in mice.

Tollefsen S, Pollock JM, Lea T, Harboe M, Wiker HG.

Scand J Immunol. 2003 Feb;57(2):151-61.

35.

Cross-reaction between mammalian cell entry (Mce) proteins of Mycobacterium tuberculosis.

Harboe M, Christensen A, Ahmad S, Ulvund G, Harkness RE, Mustafa AS, Wiker HG.

Scand J Immunol. 2002 Dec;56(6):580-7.

36.

Identification of the causative organism of tuberculous lymphadenitis in ethiopia by PCR.

Kidane D, Olobo JO, Habte A, Negesse Y, Aseffa A, Abate G, Yassin MA, Bereda K, Harboe M.

J Clin Microbiol. 2002 Nov;40(11):4230-4.

37.

Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation.

Tollefsen S, Tjelle T, Schneider J, Harboe M, Wiker H, Hewinson G, Huygen K, Mathiesen I.

Vaccine. 2002 Sep 10;20(27-28):3370-8.

PMID:
12213407
38.

[Immunology and control of tuberculosis].

Harboe M.

Tidsskr Nor Laegeforen. 2001 Jan 10;121(1):88-91. Review. Norwegian. No abstract available.

PMID:
12013623
39.

Generation of antibodies to the signal peptide of the MPT83 lipoprotein of Mycobacterium tuberculosis.

Harboe M, Whelan AO, Ulvund G, McNair J, Pollock JM, Hewinson RG, Wiker HG.

Scand J Immunol. 2002 Jan;55(1):82-7.

40.

Characterization of the secreted MPT53 antigen of Mycobacterium tuberculosis.

Johnson S, Brusasca P, Lyashchenko K, Spencer JS, Wiker HG, Bifani P, Shashkina E, Kreiswirth B, Harboe M, Schluger N, Gomez M, Gennaro ML.

Infect Immun. 2001 Sep;69(9):5936-9.

41.

25th Kellersberger memorial lecture, 2000. The contribution of immunology to tuberculosis control.

Harboe M.

Ethiop Med J. 2001 Jan;39(1):75-82. No abstract available.

PMID:
11338470
42.

Novel monoclonal antibodies against major antigens of Mycobacterium bovis.

Lyashchenko KP, Wiker HG, Harboe M, McNair J, Komissarenko SV, Pollock JM.

Scand J Immunol. 2001 May;53(5):498-502.

43.

Leprosy at a turning point?

Harboe M.

Int J Lepr Other Mycobact Dis. 2000 Sep;68(3):312-8. No abstract available.

PMID:
11221095
44.

Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection.

Hernández-Pando R, Jeyanathan M, Mengistu G, Aguilar D, Orozco H, Harboe M, Rook GA, Bjune G.

Lancet. 2000 Dec 23-30;356(9248):2133-8.

PMID:
11191539
45.

Clarification to Rada-Schlaefli, et al.

Iyer A, Mistry N, Antia N, Harboe M.

Int J Lepr Other Mycobact Dis. 2000 Mar;68(1):63-4. No abstract available.

PMID:
10834071
47.
48.

The mammalian cell entry operon 1 (mce1) of mycobacterium leprae and mycobacterium tuberculosis.

Wiker HG, Spierings E, Kolkman MA, Ottenhoff TH, Harboe M.

Microb Pathog. 1999 Sep;27(3):173-7.

PMID:
10455007
49.

Searching for secreted proteins of Mycobacterium leprae.

Harboe M, Wiker HG.

Indian J Lepr. 1999 Jan-Mar;71(1):19-35.

PMID:
10439323
50.

Cloning, expression and significance of MPT53 for identification of secreted proteins of Mycobacterium tuberculosis.

Wiker HG, Michell SL, Hewinson RG, Spierings E, Nagai S, Harboe M.

Microb Pathog. 1999 Apr;26(4):207-19.

PMID:
10089161

Supplemental Content

Loading ...
Support Center